Predictors of Response to Terlipressin in Hepatorenal Syndrome

Clin Gastroenterol Hepatol. 2018 Jul;16(7):1174. doi: 10.1016/j.cgh.2018.03.011. Epub 2018 Mar 15.

Authors

Ayse L Mindikoglu¹, Stephen C Pappas²

Affiliations

¹ Michael E. DeBakey Department of Surgery, Division of Abdominal Transplantation, Margaret M. and Albert B. Alkek Department of Medicine, Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas.
² Margaret M. and Albert B. Alkek Department of Medicine, Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Comment

MeSH terms

Hepatorenal Syndrome*
Humans
Lypressin
Terlipressin
Vasoconstrictor Agents

Substances

Vasoconstrictor Agents
Lypressin
Terlipressin

Grants and funding

P30 DK056338/DK/NIDDK NIH HHS/United States